Men Spend More Per Neurotoxin Visit as Treatment Doses Rise: Report
Key Takeaways
- Guidepoint Qsight reports that US men spent an average of $529.43 per neurotoxin transaction in Q3 2026, the highest level in nearly 5 years of its tracking.
- Male and female patients paid approximately the same amount per unit, according to Qsight, but men received 10% to 15% more units per visit on average.
- The report described geographic and generational differences in male neurotoxin use, including a concentration among Millennial men.
Men are spending more per visit on neurotoxin treatments than women, according to a new report from Guidepoint Qsight.
The report, The Brotox Boom: Male Neurotoxin Spending Hits Record High, reported that the average US male neurotoxin transaction reached $529.43 in the third quarter of 2026, which was the highest amount recorded in nearly 5 years of by the firm.
Male Neurotoxin Patients Receive Higher Doses
The spending difference appears to reflect treatment volume rather than higher prices, according to a press announcement about the report. Qsight’s proprietary transaction data indicate that men and women pay approximately the same price per unit, while male patients receive 10% to 15% more neurotoxin units per visit on average.
The report draws on transaction-level data from thousands of medical aesthetics practices across the United States. Qsight also examined how male neurotoxin spending patterns have changed over time and vary by geography and generation. According to the report, the spending gap between male and female patients had narrowed over the previous 4 years before an outlying increase in Q3 2026. The analysis also identified regional differences in male neurotoxin spending.
Millennial men accounted for a disproportionate share of male neurotoxin patients. Shares represented by Baby Boomers and Generation Z were nearly identical between male and female patients.